About Incept BioSystems
Incept BioSystems is a company based in Ann Arbor (United States) founded in 2005 was acquired by Origio in December 2010. Incept BioSystems has raised $3.29 million across 9 funding rounds from investors including HHS, Plymouth Growth and Michigan Economic Development. Incept BioSystems operates in a competitive market with competitors including 10X Genomics, Mission Bio, MaxCyte, SQZBiotech and Cellares, among others.
- Headquarter Ann Arbor, United States
- SectorsHealthcare
- Website inceptbio.com
- Social LinkedIn
- Acquired by Origio (Dec 2010)
Funding Insights of Incept BioSystems
Incept BioSystems has successfully raised a total of $3.29M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $127.61 thousand completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.29M
- Total Rounds 9
- Last Round Grant — $127,608
- Investors Count 5
All 9 funding rounds of Incept BioSystems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2010 | $127,608 | Grant | – | – | |
| Jan 2009 | $1.25M | Debt – Conventional | – | – | |
| Apr 2007 | $3.25M | Series A | – | – | |
| Dec 2006 | – | Series A | – | – | |
| Jun 2005 | $35,000 | Seed | – | – | – |
| Apr 2005 | $2,000 | Grant | – | – | – |
| Apr 2005 | – | Grant | – | – | – |
| Apr 2005 | – | Grant | – | – | – |
| Apr 2005 | $7,500 | Grant | – | – |
6 investors in total: 6 institutional.
Investors in Incept BioSystems
Incept BioSystems has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Plymouth Growth and Michigan Economic Development.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple sectors focused seed & early stage VC firm investing in the US, Europe & Asia | – | ventureinvestors.com | Madison, United States | |
Growth stage tech & offline focused VC firm funding companies in the US | 2003 | plymouthgp.com | Ann Arbor, United States | |
Finger Interests, Ltd. is operated as a family office in Houston. | 1996 | fingerinterests.com | Houston, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Economic development in Michigan is advanced by the foundation. | 1997 | michiganadvantage.org | Lansing, United States | |
CooperSurgical is engaged in providing fertility and women's health solutions. | – | origio.com | Trumbull, USA |
Investor details for Incept BioSystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Incept BioSystems
4 dated milestones of Incept BioSystems across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Incept BioSystems is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $128K.
- Exit Acquired by Origio.
Competitors of Incept BioSystems
Incept BioSystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, MaxCyte, SQZBiotech and Cellares, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 10xgenomics.com | 2012 | Pleasanton, United States | $199.9M | 961 | Instrument systems for genomic research and sequencing libraries are developed. | |
| missionbio.com | 2014 | San Francisco, United States | $110M | 109 | Single-cell multi-omics platform is provided for genotypic and phenotypic analysis. | |
| maxcyte.com | 1998 | Gaithersburg, United States | $20.69M | 71 | Instrument systems for cell processing and modification are provided. | |
| sqzbiotech.com | 2013 | Boston, United States | $167.41M | 117 | Cell therapies are developed using proprietary Cell Squeeze technology. | |
| cellares.com | 2019 | San Francisco, United States | $355M | – | Medical devices for cell-based therapy manufacturing are produced. | |
| lumicks.com | 2014 | Amsterdam, Netherlands | $93.38M | – | Optical tweezers instruments for single-molecule analysis are manufactured. | |
| xcellbio.com | 2012 | San Francisco, United States | $40.9M | 11 | Cell culture analysis devices for cancer research are developed. | |
| berkeleylights.com | 2011 | Emeryville, United States | $124.72M | 267 | Microfluidics-based systems for single-cell isolation and analysis are developed. | |
| levitasbio.com | 2017 | San Francisco, United States | $73.77M | – | Single-cell imaging platform developed via magnetic levitation technology. |
Detailed competitors of Incept BioSystems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Incept BioSystems
10 companies that operate in the same segment as Incept BioSystems (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Incept BioSystems
Incept BioSystems was founded in 2005.
Incept BioSystems is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Incept BioSystems is a funded company, having raised a total of $3.29M across 9 funding rounds to date. The company's 1st funding round was a Grant of $2K, raised on Apr 2005.
Incept BioSystems was founded in 2005 in Ann Arbor, United States, and operates within the biotechnology sector focused on assisted reproductive technologies. Proprietary microscale SMART systems are utilized to develop devices that replicate in vivo conditions for embryo and oocyte culture. These tools support in vitro manipulation and viability enhancement of high-value cells, aiding IVF treatments in reproductive labs across the domain of inceptbio.com.
Incept BioSystems's top competitors include MaxCyte, 10X Genomics and Mission Bio.
Incept BioSystems has 6 investors. Key investors include HHS, Plymouth Growth, Michigan Economic Development, Venture Investors, and Finger Interests.
Yes. Incept BioSystems was acquired by Origio in December 2010.